https://www.selleckchem.com/products/LY294002.html
015; with FOUR p = 0.026). Combining NSE measurement and initial neurological examination improved the prediction of neurological outcomes.The better understanding of the safety of biologic DMARDs (bDMARDs), as well as the emergence of new bDMARDs against different therapeutic targets and biosimilars have likely influenced the use patterns of these compounds over time. The aim of this study is to assess changes in demographic characteristics, disease activity and treatment patterns in patients with rheumatoid arthritis (RA), psoriatic
Like
Comment
Share
